Rxo (RXO) Change in Account Payables (2021 - 2026)

Rxo (RXO) has 6 years of Change in Account Payables data on file, last reported at $49.0 million in Q1 2026.

• Quarterly Change in Account Payables rose 187.5% year-over-year to $49.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.0 million (up 211.25% YoY) and the FY2025 annual result came in at -$16.0 million, up 75.38% from the prior year.
• Change in Account Payables fell to $49.0 million in Q1 2026, from $58.0 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $216.0 million in Q1 2022 to a low of -$121.0 million in Q2 2022.
• A 5-year average of -$7.8 million and a median of -$20.0 million in 2024 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 422.22% in 2025, down 364.29% in 2025.
• Tracing RXO's Change in Account Payables over 5 years: stood at -$39.0 million in 2022, then advanced by 23.08% to -$30.0 million in 2023, then jumped by 40.0% to -$18.0 million in 2024, then jumped by 422.22% to $58.0 million in 2025, then retreated by 15.52% to $49.0 million in 2026.
• The last three Change in Account Payables figures came in at $49.0 million (Q1 2026), $58.0 million (Q4 2025), and $19.0 million (Q3 2025), per Business Quant data.